CLSA Board of Directors

Wade Ackerman

Partner, Covington & Burling LLP

William Annett

Chief Executive Officer OncoCyte

Michael V. Arbige, Ph.D.

Vice President of R&D, DuPont Biosciences

Rick Ascroft

VP, Managed Market and Government Affairs, Takeda Pharmaceuticals USA, Inc.

Ranjeet Banerjee

Worldwide President, Medication Management Solutions, Becton, Dickinson And Company (BD)

David Beier, J.D.

Managing Director, Bay City Capital

Fritz Bittenbender

Senior Vice President, Government Affairs, Genentech

Seng H. Cheng, Ph.D.

Molecular Biology, Neuroscience, Biotechnology Ph.D., Global Head of Research, Rare Disease, Genzyme, a Sanofi Company

Ho Sung Cho

Vice President, Biotherapeutics, Celgene

Peter J. Claude

Partner, PwC

Bill Fairey

President, Actelion Pharmaceuticals US

Robert B. Ford

Executive Vice President, Medical Devices, Abbott

Mark Ginestro

Principal, Healthcare and Life Sciences, KPMG

Bryan Giraudo

Managing Director, Investment Banking, Leerink Partners LLC

Paul Hastings

President and Chief Executive Officer, OncoMed Pharmaceuticals

Vera Janushkowsky

Vice President, Government Relations Pfizer Inc.

Steve A. Kay, Ph.D., D.Sc.

Director of Convergent Bioscience, Provost Professor of Neurology, Biomedical Engineering and Biological Sciences, University of Southern California

Alex Kelly

Executive Vice President, Chief Communications Officer | Allergan

Larry Kwak, M.D., Ph. D.

Vice President and Cancer Center Associate Director
Director, Toni Stephenson Lymphoma Center...

John Maddalon

Principal, Deloitte Consulting LLP | Life Sciences

Sean McCarthy

Chief Executive Officer, CytomX

Shlomo Melmed, MB, ChB, MACP

Executive Vice President for Academic Affairs and Dean of the Medical Faculty at Cedars-Sinai Health System

John Melo

Chief Executive Officer, Amyris, Inc.

Alan Mendelson

Senior Partner and Co-Chair, Venture Technology Group, Latham & Watkins LLP

Jim Meyers

Executive Vice President, Worldwide Commercial Operations, Gilead Sciences

Peter G. Milner M.D., F.A.C.C.

Chairman, Armetheon

Keith Murphy

Chairman, Organovo

John Nicols

President and Chief Executive Officer, Codexis

Christian W. Nolet

Partner and Life Sciences Industry Leader, West Region, Ernst & Young

Joshua J. Ofman M.D., M.S.H.S

Senior Vice President, Global Value, Access & Policy, Amgen

Kim Popovits

Chairman of the Board, President & CEO, Genomic Health

Michael G. Raab

President and Chief Executive Officer, Ardelyx

Stephen Richardson

Chief Operating Officer and Regional Market Director (San Francisco), Alexandria Real Estate (ARE)

Beth Roberts

Partner, Hogan Lovells US LLP

Howard W. Robin

President and Chief Executive Officer, NEKTAR

Daria Mochly-Rosen, Ph.D.

The George D. Smith Professor in Translational Medicine
Professor, Chemical and Systems Biology...

Terry Rosen, Ph.D.

Chief Executive Officer, Arcus Biosciences

George Savage M.D.

Co-Founder, Chief Medical Officer, Proteus Digital Health

Tony Semedo

Senior Vice President and President, Aortic and Peripheral Vascular, Medtronic CardioVascular (Santa Rosa)

David Stover Ph.D.

Senior Vice President, Agensys Site Head and Head of Research, Agensys, Inc

Ben Thorner

Senior Vice President and Head of Business Development & Licensing | Merck

Harold E. Van Wart, Ph.D.

Jens Vogel, Ph.D.

President and CEO | Boehringer Ingelheim

Rick E Winningham

Chairman and CEO, Theravance Biopharma, Inc.